A maternal serum screening test is a prenatal blood test that measures specific substances in a pregnant woman's blood to estimate the risk of certain chromosomal conditions or pregnancy-related complications. Depending on the type of screening, the test may help assess the likelihood of Down syndrome, Edwards syndrome, and neural tube defects in the developing baby. MedGenome offers genetic testing and reproductive genomics services that can help expectant parents and healthcare professionals explore appropriate prenatal testing options.
Maternal serum screening is an important part of prenatal care because it provides information about pregnancy risks without requiring an invasive procedure. However, it is a screening test rather than a diagnostic test, meaning an abnormal result does not confirm that the baby has a particular condition.
What Is a Maternal Serum Screening Test?
A maternal serum screening test analyses selected biochemical markers in the mother's blood during pregnancy. These markers may include pregnancy-associated plasma protein A (PAPP-A), human chorionic gonadotropin (hCG), alpha-fetoprotein (AFP), unconjugated estriol (uE3), and inhibin A.
The markers measured depend on the screening method and the stage of pregnancy. Their levels are assessed alongside factors such as gestational age, maternal age, and other relevant clinical information to estimate the likelihood of selected fetal conditions.
Maternal serum screening does not directly examine the baby's chromosomes. Instead, it uses statistical risk assessment to determine whether additional testing may be appropriate.
What Are the Different Types of Maternal Serum Screening Tests?
Maternal serum screening can be performed during the first or second trimester, depending on the test.
1. First-Trimester Combined Screening
First-trimester combined screening typically includes a maternal blood test measuring PAPP-A and free beta-hCG, together with an ultrasound measurement called nuchal translucency.
The combined results help estimate the likelihood of Down syndrome and Edwards syndrome.
This screening is generally performed between 11 weeks and 13 weeks and 6 days of pregnancy, depending on the protocol and the ultrasound measurements required.
2. Second-Trimester Triple Marker Test
The triple marker test measures three substances in maternal blood:
Alpha-fetoprotein (AFP)
Human chorionic gonadotropin (hCG)
Unconjugated estriol (uE3)
The results are combined with maternal and pregnancy information to estimate the risk of selected chromosomal conditions and, in some screening protocols, open neural tube defects.
3. Quadruple Marker Test
The quadruple marker test, also called the quad screen, measures four substances: AFP, hCG, uE3, and inhibin A.
It is generally performed during the second trimester and helps estimate the likelihood of Down syndrome, Edwards syndrome, and open neural tube defects.
The exact conditions assessed and the test's performance depend on the screening protocol used by the laboratory.
4. Maternal Serum AFP Test
Maternal serum AFP testing measures alpha-fetoprotein in the mother's blood. Higher or lower levels can be associated with different pregnancy conditions, although many factors can affect the result.
Elevated AFP may indicate an increased likelihood of an open neural tube defect, such as spina bifida, or certain abdominal wall defects. It can also occur for reasons unrelated to a fetal abnormality.
An abnormal AFP result requires interpretation alongside gestational age, ultrasound findings, and other clinical information.
When Is the Maternal Serum Screening Test Done?
The recommended timing depends on the type of screening.
Screening test | Typical timing |
|---|---|
First-trimester combined screening | Approximately 11 to 13 weeks and 6 days |
Triple marker test | Usually 15 to 22 weeks |
Quadruple marker test | Usually 15 to 22 weeks |
Maternal serum AFP | Commonly 15 to 22 weeks |
Some tests have narrower preferred testing windows. The laboratory and healthcare provider should confirm the appropriate timing before sample collection.
Accurate gestational age is particularly important because marker levels change throughout pregnancy. Incorrect pregnancy dating can affect the interpretation of the screening result.
Why Is Maternal Serum Screening Important?
Maternal serum screening can help expectant parents and healthcare professionals identify pregnancies that may need further assessment.
Early Risk Assessment
First-trimester screening can provide an early estimate of the likelihood of selected chromosomal conditions, allowing time to discuss additional testing options.
Screening for Neural Tube Defects
Maternal serum AFP testing can help identify pregnancies with an increased likelihood of certain open neural tube defects. Ultrasound and additional investigations may be recommended when AFP levels are abnormal.
Supporting Informed Decisions
The results can help parents discuss the benefits, limitations, and timing of further prenatal screening or diagnostic procedures with their healthcare provider.
Avoiding Unnecessary Invasive Testing
A low-risk screening result may help reduce the need for additional investigations in some situations. However, screening results should never replace other tests that are clinically indicated.
How Is the Maternal Serum Screening Test Performed?
The procedure is generally straightforward and involves collecting a blood sample from the pregnant woman.
Step 1: Pregnancy assessment. The healthcare provider reviews gestational age, maternal age, pregnancy history, and any relevant ultrasound findings.
Step 2: Blood sample collection. A trained professional collects blood from a vein in the arm. Fasting is generally not required, but patients should follow the laboratory's instructions.
Step 3: Laboratory analysis. The laboratory measures the markers required for the selected screening test.
Step 4: Risk calculation. The marker levels are combined with relevant clinical information to calculate an estimated risk for the conditions covered by the test.
Step 5: Result interpretation. The healthcare provider explains the result and recommends further evaluation if necessary.
The test itself does not usually pose a direct risk to the fetus because it requires only a maternal blood sample.
What Do Maternal Serum Screening Results Mean?
Results are generally reported as a risk estimate rather than a definite diagnosis.
Result | General meaning |
|---|---|
Low risk | The likelihood of the screened condition is lower, but not completely eliminated |
High risk | The likelihood is higher, and additional assessment may be recommended |
Inconclusive | The test did not provide a reliable risk estimate and may need further evaluation |
A high-risk result does not mean that the baby definitely has a chromosomal condition. The healthcare provider may recommend further evaluation, such as detailed ultrasound, non-invasive prenatal testing (NIPT), genetic counselling, or diagnostic testing with chorionic villus sampling or amniocentesis.
The choice depends on the pregnancy stage, screening result, and individual clinical circumstances.
Maternal Serum Screening vs NIPT
Maternal serum screening and non-invasive prenatal testing are different approaches to prenatal screening.
Feature | Maternal serum screening | NIPT |
|---|---|---|
Sample | Maternal blood | Maternal blood |
Analysis | Biochemical markers, sometimes combined with ultrasound | Cell-free DNA, including DNA fragments originating from the placenta |
Main purpose | Estimates risk for selected chromosomal conditions and, in some tests, neural tube defects | Screens primarily for selected chromosomal abnormalities |
Accuracy for common trisomies | Generally lower than NIPT | Generally higher for Down syndrome and other common trisomies |
Neural tube defect screening | AFP-based screening can help assess risk | Does not replace AFP screening or ultrasound for neural tube defects |
NIPT is generally more accurate than conventional serum screening for common trisomies, but it remains a screening test. The most appropriate option depends on individual circumstances, availability, and healthcare guidance.
Maternal Serum Screening and MedGenome
MedGenome provides genetic testing and reproductive genomics services. Expectant parents researching prenatal screening can discuss available options with their obstetrician and confirm whether a specific screening or diagnostic service is offered by the provider.
It is important to distinguish between maternal serum screening and genetic testing. Maternal serum screening measures biochemical markers in the mother's blood, whereas genetic tests analyse DNA or chromosomes to investigate selected genetic conditions.
Depending on the pregnancy and clinical question, a healthcare professional may discuss options such as:
Maternal serum screening for selected pregnancy risks.
NIPT for screening selected chromosomal abnormalities.
Carrier screening for selected inherited conditions.
Diagnostic genetic testing when indicated by clinical findings.
The correct test depends on the purpose of screening, gestational age, medical history, and the advice of a qualified healthcare professional. Patients should confirm the current availability, cost, and scope of any service directly with the provider.
What Factors Can Affect Maternal Serum Screening Results?
Several factors can influence the interpretation of a maternal serum screening test.
Gestational age: Marker levels change as pregnancy progresses, so accurate dating is essential.
Maternal age: Age may be included in the calculation of the likelihood of certain chromosomal conditions.
Multiple pregnancy: Marker levels and risk calculations differ for twin or higher-order pregnancies.
Maternal weight and medical history: These details may affect how laboratory results are interpreted.
Other pregnancy factors: Certain medications, maternal conditions, and pregnancy characteristics may influence marker levels or the reliability of the screening estimate.
An unexpected result should be reviewed by a healthcare professional rather than interpreted in isolation.
Frequently Asked Questions
Is the maternal serum screening test safe?
Yes. It involves collecting a blood sample from the pregnant woman and does not directly involve the fetus.
Does a high-risk result confirm Down syndrome?
No. Maternal serum screening estimates the likelihood of Down syndrome. Further screening or diagnostic testing may be recommended to clarify the result.
Is fasting required before maternal serum screening?
Fasting is generally not required for common maternal serum screening tests. Follow any specific instructions provided by the laboratory.
Can maternal serum screening detect neural tube defects?
Maternal serum AFP testing can help identify pregnancies with an increased likelihood of certain open neural tube defects. Ultrasound and additional investigations may be needed.
Which is better, maternal serum screening or NIPT?
For screening common chromosomal conditions such as Down syndrome, NIPT generally has higher sensitivity and specificity than conventional serum screening. However, maternal serum AFP and ultrasound can provide information about neural tube defects that NIPT does not replace.
Does MedGenome offer maternal serum screening?
MedGenome provides genetic testing and reproductive genomics services. Patients should confirm directly with the provider whether a specific maternal serum screening test is available and appropriate for their pregnancy.
Conclusion
The maternal serum screening test is a useful part of prenatal care because it helps estimate the likelihood of selected chromosomal conditions and, in certain tests, neural tube defects. The appropriate screening method depends on the stage of pregnancy, clinical history, and the information needed.
MedGenome offers genetic testing and reproductive genomics services that may be relevant when additional prenatal genetic evaluation is being considered. However, maternal serum screening, NIPT, and diagnostic genetic tests serve different purposes.
Expectant parents should discuss their options with an obstetrician or qualified genetic counsellor, understand the limitations of screening, and arrange further assessment when recommended.
Medical disclaimer: This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
